The president of Mexico, Claudia Sheinbaum, has openly criticized the classification of fentanyl as a mass destruction weapon by the President of the United States, Donald Trump. This measure, announced recently, generates concern in Mexico over its possible effects on the legal medical use of the drug, essential for treatments against chronic pain and palliative care.
Mexico’s focus on prevention and public health
Sheinbaum defends a national strategy centered on public health, prevention, and social causes of drug consumption. “If the causes are not addressed, it will be fentanyl or another drug”, stated the head of government, emphasizing the need to address factors such as mental health, family environment, and education, especially among young people. Mexico pursues crimes through prosecutors and judges, but prioritizes integral solutions.
Mass destruction weapon: implications for medical fentanyl
Analysis of the scope of the US decision
The Mexican Government evaluates the scope of this designation, which Trump links to the opioid crisis in the US, where fentanyl causes over 70,000 annual deaths from overdose, according to data from the Centers for Disease Control and Prevention (CDC). Historically, Mexico has fought the trafficking of chemical precursors from China, seizing tons in joint operations with US agencies. However, Sheinbaum warns that labeling fentanyl as a mass destruction weapon could restrict its legitimate pharmaceutical production, affecting oncological and post-surgical patients.
Experts in public health, such as those from the National Institute of Public Health, support this view. Next week, Mexico will publish the results of a national survey on drug consumption, revealing patterns linked to social inequalities. In 2024, Mexico reported 15,000 deaths related to fentanyl, but insists that 90% of the traffic comes from US routes.
Bilateral context and background
This criticism arises after meetings between Sheinbaum and Trump, including a confirmed meeting in Washington before the 2026 World Cup draw. Both countries share a border and challenges: the US accuses Mexican cartels of exporting fentanyl, while Mexico highlights record seizures, such as 1,500 kg in 2025. Organizations such as the UN recommend evidence-based approaches, combining repression and treatment.
- Key factors in consumption: mental health and education.
- Mexican measures: strengthening prevention.
- Risks: impact on essential medications.
Sheinbaum has exposed this position directly to Trump, promoting cooperation without stigmatizing medical fentanyl. The debate over fentanyl as a mass destruction weapon highlights bilateral tensions in security and health, with Mexico betting on root causes for a lasting solution.
